Literature DB >> 32155265

Emergence of OXA-232-producing hypervirulent Klebsiella pneumoniae ST23 causing neonatal sepsis.

Subhankar Mukherjee1, Sharmi Naha1, Punyasloke Bhadury2, Bijan Saha3, Moumita Dutta4, Shanta Dutta1, Sulagna Basu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32155265     DOI： 10.1093/jac/dkaa080

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Molecular Epidemiology of Hypervirulent K. pneumoniae and Problems of Health-Care Associated Infections.

Authors:  A V Tutelyan; D S Shlykova; Sh L Voskanyan; A M Gaponov; V M Pisarev
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.737

2.  The Characterization of OXA-232 Carbapenemase-Producing ST437 Klebsiella pneumoniae in China.

Authors:  Xingbei Weng; Qiucheng Shi; Sheng Wang; Yubo Shi; Dinghe Sun; Yunsong Yu
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-07-08       Impact factor: 2.471

3.  OXA-181-Like Carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from Septicemic Neonates: Coexistence with NDM-5, Resistome, Transmissibility, and Genome Diversity.

Authors:  Sharmi Naha; Kirsty Sands; Subhankar Mukherjee; Bijan Saha; Shanta Dutta; Sulagna Basu
Journal:  mSphere       Date:  2021-01-13       Impact factor: 4.389

4.  Outbreak of Multidrug-Resistant OXA-232-Producing ST15 Klebsiella pneumoniae in a Teaching Hospital in Wenzhou, China.

Authors:  Huaiyu Jia; Ying Zhang; Jianzhong Ye; Wenya Xu; Ye Xu; Weiliang Zeng; Wenli Liao; Tao Chen; Jianming Cao; Qing Wu; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2021-10-24       Impact factor: 4.003

5.  Multidrug-resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil.

Authors:  Rafael Nakamura-Silva; Louise Cerdeira; Mariana Oliveira-Silva; Karen Regina Carim da Costa; Elder Sano; Bruna Fuga; Quézia Moura; Fernanda Esposito; Nilton Lincopan; Kelly Wyres; André Pitondo-Silva
Journal:  Arch Microbiol       Date:  2022-03-04       Impact factor: 2.667

Review 6.  Early-Onset Neonatal Sepsis in Low- and Middle-Income Countries: Current Challenges and Future Opportunities.

Authors:  Kirsty Sands; Owen B Spiller; Kathryn Thomson; Edward A R Portal; Kenneth C Iregbu; Timothy R Walsh
Journal:  Infect Drug Resist       Date:  2022-03-09       Impact factor: 4.003

7.  Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids.

Authors:  Zackery P Bulman; Xing Tan; Ting-Yu Chu; Yanqin Huang; Amisha P Rana; Nidhi Singh; Stephanie A Flowers; Yasuhiro Kyono; Barry N Kreiswirth; Liang Chen
Journal:  Comput Struct Biotechnol J       Date:  2022-07-15       Impact factor: 6.155

Review 8.  Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae.

Authors:  Yu-Ling Han; Xu-Hui Wen; Wen Zhao; Xi-Shan Cao; Jian-Xun Wen; Jun-Rui Wang; Zhi-De Hu; Wen-Qi Zheng
Journal:  Front Microbiol       Date:  2022-09-12       Impact factor: 6.064

Review 9.  Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae.

Authors:  Subhankar Mukherjee; Shravani Mitra; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2021-06-11

10.  One Health Genomic Study of Human and Animal Klebsiella pneumoniae Isolated at Diagnostic Laboratories on a Small Caribbean Island.

Authors:  Patrick Butaye; Marc Stegger; Arshnee Moodley; Peter Damborg; Andrea Williams; Iona Halliday-Simmonds; Luca Guardabassi
Journal:  Antibiotics (Basel)       Date:  2021-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.